research funding database


This opportunity is currently closed.

Sign up for Content alerts to stay informed when this or related funding opportunities are posted.

Neurofibromatosis Research Program: Exploration – Hypothesis Development Award (worldwide)

Share this post

funding consultation boking
Text on a blue background says "Want to find funding & get support for grant-writing?" Logos of scientifyRESEARCH & GrantDesk appear below on a white background and an orange play symbol appears between the two logos. An arrow mark points to the logos.

The Neurofibromatosis Research Program: Exploration – Hypothesis Development Award from the Congressionally Directed Medical Research Programs (CDMRP) supports the initial exploration of innovative, high-risk, high-gain, and potentially groundbreaking concepts in NF research. Studies supported by this award mechanism are expected to lay the groundwork for future avenues of scientific investigation. The proposed research project should include a well-formulated, testable hypothesis based on strong scientific rationale and study design. The presentation of preliminary and/or published data is not required. The program is open to researchers in the USA and worldwide. Applications are open to academic institutions as well as biotechnology companies. Investigators at all academic levels (or equivalent) may be named by the organization as the PI on the application.

The award provides up to 100,000 USD over 2 years. Indirect costs may be covered.

Funding Opportunity Number: HT9425-23-NFRP-EHDA

Pre-Application Submission Deadline: 5:00 p.m. Eastern time (ET), August 11, 2023. Application Submission Deadline: 11:59 p.m. ET, August 25, 2023.

The grant has closed Sign-up for our content alerts to be updated when it re-opens.

Adverts. Premium members do not see Google Ads.

Please Login / Subscribe to our premium membership to see the content. Sign up to Free trial to see detailed funding information.

non member

Sign-up for the
monthly funding newsletter

unsubscribe at any time